瑞科生物-B

02179
3.9000.00% ( 0.000 )
延迟 已收盘: 11月20日 16:08:00

股东

全部股东

股东类型

  • 私营企业31.60%
  • 公众及其他17.06%
  • 机构投资者16.66%
  • 员工持股计划13.74%
  • 其他20.94%

主要股东

主要股东 最新
股东
Yangtze River Pharmaceutical Group Co. Ltd
23.20%1.43 亿0.00%+0
Taizhou Yuangong Technology Partnership (Limited Partnership)
13.43%8,286.36 万0.00%+0
Lhasa Junqi Enterprise Management Co., Ltd.
6.79%4,186.10 万0.00%+0
Taizhou Chaorui Medical Technology Partnership (Limited Partnership)
6.06%3,739.00 万0.00%+0
Hongyan Liu
5.68%3,503.79 万0.00%+0
Lyfe Capital
5.59%3,449.98 万2.94%+1,815.17 万
Shenzhen Qianhai Woying Investment Management Co., Ltd
4.41%2,720.37 万0.00%+0
Jiangsu Zhaoyin Industry Fund Management Co., Ltd.
4.11%2,536.92 万0.00%+0
Shenzhen Oriental Fortune Venture Capital Management Co., Ltd.
2.64%1,630.09 万0.00%+0
Shenzhen Fuhai Xinwan Equity Investment Fund Management Enterprise (L.P.)
2.56%1,577.06 万0.00%+0
Yangtze River (Hong Kong) Limited
2.05%1,261.85 万0.00%+0
Yong LiuFounder, Executive Director & GM
1.99%1,229.42 万0.00%+0
Sequoia Capital Operations LLC
1.45%896.25 万0.00%+0
Legend Capital Management Co., Ltd.
0.96%592.14 万0.00%+0
Haoyu XuNon-Executive Chairman
0.64%395.75 万0.00%+0
Shenzhen Oriental Fortune Capital Co., Ltd.
0.31%191.44 万0.00%+0
Taizhou Baibei Biology Technology Partnership (Limited Partnership)
0.25%152.50 万0.00%+0
Shenzhen Qianhai Kekong Hong Kong-Shenzhen Venture Capital Co., Ltd.
0.21%132.17 万0.00%+0
Jiayi Zhao
0.21%128.15 万0.00%+0
Taizhou Xinchuan Law Firm (Limited Partnership)
0.17%106.91 万0.00%+0